Piet Gros

Piet Gros

Auto-generated profile, based on publicly available information

Piet Gros

Utrecht University

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1998 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
ABA T Brünger
A T Brünger
PAP D Adams
P D Adams
GCG M Clore
G M Clore
WDW L DeLano
W L DeLano
PGP Gros
P Gros
GWG L Warren
G L Warren

14 March 2014 in Science
Verified
Journal Article
Closed access
PDF file
CDChristoph A. Diebolder
Christoph A. Diebolder
FBFrank J. Beurskens
Frank J. Beurskens
RJRob N. de Jong
Rob N. de Jong
RKRoman Koning
Roman Koning
KSKristin Strumane
Kristin Strumane
PPPaul W. H. I. Parren
Paul W. H. I. Parren
Hexing Complement: Complement activation is an immediate and potent immune defense mechanism, but how immunoglobulin G (IgG) antibodies activate complement at the molecular level is poorly understood. Using high-resolution crystallography, Diebolder et al. (p. 1260 ) show that human IgGs form hexameric structures by interacting with neighboring IgG molecules, and the complex then activates complement. Thus, IgG molecules and the complement system can coexist in the blood because complement activation will only be triggered after IgG senses a surface antigen and starts to aggregate.

14 February 2014 in Genes & Development
Verified
Journal Article
Open access
PDF file
WLWim de Lau
Wim de Lau
WPWeng Chuan Peng
Weng Chuan Peng
PGPiet Gros
Piet Gros
Hans CleversHans Clevers
Hans Clevers
Lgr5 was originally discovered as a common Wnt target gene in adult intestinal crypts and colon cancer. It was subsequently identified as an exquisite marker of multiple Wnt-driven adult stem cell types. Lgr5 and its homologs, Lgr4 and Lgr6, constitute the receptors for R-spondins, potent Wnt signal enhancers and stem cell growth factors. The Lgr5/R-spondin complex acts by neutralizing Rnf43 and Znrf3, two transmembrane E3 ligases that remove Wnt receptors from the stem cell surface. Rnf43/Znrf3 are themselves encoded by Wnt target genes and constitute a negative Wnt feedback loop. Thus, adult stem cells are controlled by an intricate interplay of potent Wnt agonists, antagonists, and anti-antagonists.

1 September 2005 in Nature
Verified
Journal Article
Closed access
PDF file
BJBert J. C. Janssen
Bert J. C. Janssen
EHEric G. Huizinga
Eric G. Huizinga
HRHans C. A. Raaijmakers
Hans C. A. Raaijmakers
ARAnja Roos
Anja Roos
MDMohamed R. Daha
Mohamed R. Daha
PGPiet Gros
Piet Gros

26 October 2016 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
DRDaniel Ricklin
Daniel Ricklin
EREdimara S. Reis
Edimara S. Reis
DMDimitrios C. Mastellos
Dimitrios C. Mastellos
PGPiet Gros
Piet Gros
JLJohn D. Lambris
John D. Lambris

16 August 2002 in Science
Verified
Journal Article
Closed access
PDF file
EHEric G. Huizinga
Eric G. Huizinga
STShizuko Tsuji
Shizuko Tsuji
RRRoland A. P. Romijn
Roland A. P. Romijn
MSMarion E. Schiphorst
Marion E. Schiphorst
PGPhilip G. de Groot
Philip G. de Groot
PGPiet Gros
Piet Gros
Transient interactions of platelet-receptor glycoprotein Ibα (GpIbα) and the plasma protein von Willebrand factor (VWF) reduce platelet velocity at sites of vascular damage and play a role in haemostasis and thrombosis. Here we present structures of the GpIbα amino-terminal domain and its complex with the VWF domain A1. In the complex, GpIbα wraps around one side of A1, providing two contact areas bridged by an area of solvated charge interaction. The structures explain the effects of gain-of-function mutations related to bleeding disorders and provide a model for shear-induced activation. These detailed insights into the initial interactions in platelet adhesion are relevant to the development of antithrombotic drugs.